PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
- Author(s):
- Heerik, A.S.V.M. van den; Horeweg, N. (0000-0002-8581-4753); Nout, R.A.; Lutgens, L.C.H.W.; Steen-banasik, E.M. van der; Westerveld, G.H.; Berg, H.A. van den; Slot, A.; Koppe, F.L.A.; Kommoss, S.; Mens, J.W.M.; Nowee, M.E.; Bijmolt, S.; Cibula, D.; Stam, T.C.; Jurgenliemk-Schulz, I.M.; Snyers, A.; Hamann, M.; Zwanenburg, A.G.; Coen, V.L.M.A.; Vandecasteele, K.; Gillham, C.; Chargari, C.; Verhoeven-Adema, K.W.; Putter, H. (0000-0001-5395-1422); Hout, W.B. van den (0000-0002-6425-0135); Wortman, B.G.; Nijman, H.W.; Bosse, T. (0000-0002-6881-8437); Creutzberg, C.L. (0000-0002-7008-4321)
- Published
- 2020
- Publication type
- Article / Letter to editor
- Date issued
- 2020-08-17
- Language
- English
- Publisher
- BMJ Publishing Group
- Is part of
- International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020), Vol. 2020, no. 30, p. 2002-2007
- hdl
- 1887/3182851
- doi
- 10.1136/ijgc-2020-001929
- URL
- https://ijgc.bmj.com/content/30/12/2002
